Trial description:
A phase III randomised , double-blind, placebo-controlled study of Atezolizumab with or without Tiragolumab (anti-tigit antibody) in patients with locally advanced esophageal squamous cell carcinoma
Contact name:
Dr Lizzie Smyth
Trial start date:
Tuesday, November 17, 2020
Trial end date:
Wednesday, December 31, 2025
Trial tumour type:
Oesophageal
Show on Radiotherapy:
No
